ABSTRACT
Extended-criteria donors (ECDs) are seen as a means of addressing the shortfall in solid-organ availability for transplant. However, the use of ECD kidneys is associated with a greater risk of primary non-function compared with standard-criteria donor kidneys, and a higher discard rate has been described internationally. There seems to be a lack of consensus in the consideration of ECD kidneys for transplant, with reliance often placed on the subjective assessment of individual clinicians. The following case examines the difference in the institutional decision-making process applied to two kidneys from a single donor, and provides an argument for the use of hypothermic machine perfusion in low- to middle-income countries as an efficacious and objective means of assessing ECD kidney suitability.
Subject(s)
Kidney Transplantation , Humans , South Africa , Perfusion/methods , Male , Tissue and Organ Procurement/methods , Adult , Tissue Donors , Donor Selection/methods , Organ Preservation/methods , Female , Middle Aged , Kidney/blood supplyABSTRACT
As a historic gold mining area, the City of Benoni has numerous water bodies close to major tailings dams and mine dumps. Here we assess spatial patterns in the sediment geochemistry of five dams and four natural pans within a 5-km radius of the core mining area to determine the degree of contamination7 by mining-associated pollutants. XRF analysis was used with a geoaccumulation index to assess the degree of contamination above background levels. Prevailing winds blow from the north and north-west with less dominant winds from the east. Sediment concentrations of As, Cu, Pb, Ni and Zn are highly correlated across the region, suggestive of a common source. Except for one pan showing evidence of local industrial pollution, the most contaminated sites are the dams to the west of the mine dumps where concentrations of As, Cu, Pb and Zn increase towards the central mining area, with highest trace metal concentrations in Kleinfontein Dam, adjacent to a reworked mine dump. Sites upwind of the central mining area showed little evidence of mining-related contamination. Trace contaminant concentrations in sediments of these dams are much greater than those found in the nearby Springs-Blesbokspruit wetlands adjacent to more recently active mines. The potential risks to aquatic ecosystems and recreational users of these urban and suburban water bodies from these wind-blown, legacy mining contaminants merit further investigation.
Subject(s)
Metals, Heavy , Soil Pollutants , Trace Elements , Water Pollutants, Chemical , Ecosystem , Environmental Monitoring , Geologic Sediments , Gold , Metals, Heavy/analysis , Mining , Soil Pollutants/analysis , South Africa , Water Pollutants, Chemical/analysisABSTRACT
AIMS: To develop an expert consensus statement regarding appropriate clinical and forensic post mortem neurological imaging. METHODS: An expert panel of clinicians were recruited from registered members of the British Neuropathological Society (BNS) and the International Society of Forensic Radiology and Imaging (ISFRI) with post mortem expertise. Following a focus group meeting, 16 core statements were incorporated into an online modified Delphi survey and each panellist was asked to score their level of agreement. Following the first iteration, two statements that failed to reach consensus were modified and re-rated. Consensus was predefined as 75% agreement across responders. RESULTS: Seventeen experts joined the panel and 12 (70.6%) attended the focus group meeting; 14 (82%) completed both iterations of the survey. Consensus was reached for need of adequate clinical history, multidisciplinary discussion, establishment of special interest groups to discuss cases, gathering further evidence to inform imaging choices, establishment of methods for quality assessment in reporting standards and adequate funding for imaging services. The panel agreed that pathologists should be responsible for neuroimaging referrals, collating results of ancillary tests, and producing the final post mortem report. Areas requiring further discussion include the impact of double reporting, indications for neuroimaging and utilities of three-dimensional printing. CONCLUSION: The BNS/ISFRI statement represents current views of an expert panel of health professionals engaged in post-mortem neuroimaging. We hope this provides a working guideline for less experienced operators, stimulates discussion and highlights the most pressing clinical and research questions.
Subject(s)
Autopsy/methods , Brain/diagnostic imaging , Neuroimaging , Brain/pathology , Consensus , Humans , Magnetic Resonance Imaging , Tomography, X-Ray ComputedABSTRACT
BACKGROUND AND PURPOSE: A number of parameters derived from dynamic contrast-enhanced MR imaging and separate histologic features have been identified as potential prognosticators in high-grade glioma. This study evaluated the relationships between dynamic contrast-enhanced MRI-derived parameters and histologic features in glioblastoma multiforme. MATERIALS AND METHODS: Twenty-eight patients with newly presenting glioblastoma multiforme underwent preoperative imaging (conventional imaging and T1 dynamic contrast-enhanced MRI). Parametric maps of the initial area under the contrast agent concentration curve, contrast transfer coefficient, estimate of volume of the extravascular extracellular space, and estimate of blood plasma volume were generated, and the enhancing fraction was calculated. Surgical specimens were used to assess subtype and were graded (World Health Organization classification system) and were assessed for necrosis, cell density, cellular atypia, mitotic activity, and overall vascularity scores. Quantitative assessment of endothelial surface area, vascular surface area, and a vascular profile count were made by using CD34 immunostaining. The relationships between MR imaging parameters and histopathologic features were examined. RESULTS: High values of contrast transfer coefficient were associated with the presence of frank necrosis (P = .005). High values of the estimate of volume of the extravascular extracellular space were associated with a fibrillary histologic pattern (P < .01) and with increased mitotic activity (P < .05). No relationship was found between mitotic activity and histologic pattern, suggesting that the correlation between the estimate of volume of the extravascular extracellular space and mitotic activity was independent of the histologic pattern. CONCLUSIONS: A correlation between the estimate of volume of the extravascular extracellular space and mitotic activity is reported. Further work is warranted to establish how dynamic contrast-enhanced MRI parameters relate to more quantitative histologic measurements, including markers of proliferation and measures of vascular endothelial growth factor expression.
Subject(s)
Brain Neoplasms/diagnostic imaging , Glioblastoma/diagnostic imaging , Magnetic Resonance Imaging/methods , Neuroimaging/methods , Adult , Brain Neoplasms/pathology , Contrast Media , Extracellular Space/diagnostic imaging , Female , Glioblastoma/pathology , Humans , Male , Middle Aged , Young AdultABSTRACT
Spinal ganglioneuromas may grow in a dumbbell fashion. We report the first case of an intradural, extramedullary ganglioneuroma in the lumbar spine and review the pertinent literature. Although rare, we propose that ganglioneuroma be considered a differential diagnosis in patients presenting with a large mass occupying both intraspinal and extraspinal compartments.
Subject(s)
Ganglioneuroma/pathology , Spinal Cord Neoplasms/pathology , Diagnosis, Differential , Female , Ganglioneuroma/physiopathology , Ganglioneuroma/surgery , Humans , Lumbar Vertebrae/pathology , Magnetic Resonance Imaging , Middle Aged , Neurofibroma/pathology , Spinal Cord Neoplasms/physiopathology , Spinal Cord Neoplasms/surgery , Treatment OutcomeABSTRACT
The diversity of Cryptosporidium at species, subtype family and subtype level in diarrhoeic children was investigated in four provinces in South Africa. A total of 442 stool samples from children <5 years of age were collected under a large rotavirus surveillance programme and analysed by Ziehl-Neelsen acid-fast staining. Fifty-four (12.2%) were positive for Cryptosporidium, of which 25 were genotyped by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) and DNA sequence analyses of the 18S rRNA gene. The majority of genotyped specimens were identified as C. hominis (76%), and a high genetic diversity was found with five different C. hominis subtype families (Ia, Ib, Id, Ie and If). Cryptosporidium parvum was found in 20% of the isolates, and three subtype families were identified (IIc, IIe and IIb), with subtype family IIc being the most common. One specimen was identified as C. meleagridis of the subtype family IIId. These results are in accordance with findings from other developing countries and report for the first time the presence in South Africa of C. meleagridis, various subtypes of C. parvum and the subtype family Ie of C. hominis. The results suggest that C. hominis and anthroponotic C. parvum subtypes are the major cause of cryptosporidiosis in South Africa. Further molecular studies are needed to better understand the epidemiology and public health importance of Cryptosporidium in humans in South Africa.
Subject(s)
Cryptosporidiosis/parasitology , Cryptosporidium/genetics , Diarrhea/parasitology , Animals , Child, Preschool , Cryptosporidiosis/epidemiology , Diarrhea/epidemiology , Genetic Variation , Humans , Infant , South Africa/epidemiologyABSTRACT
Metastatic melanoma has a propensity for multiple intra cranial deposits. Rarely, metastatic melanoma to the pituitary gland has been reported, usually in conjunction with widespread systemic metastases. We describe a patient with metastatic melanoma to the pituitary gland as the first clinical presentation of widespread metastatic disease and review the relevant literature.
Subject(s)
Melanoma/pathology , Pituitary Gland/pathology , Pituitary Neoplasms/pathology , Aged , Humans , Magnetic Resonance Imaging , Male , Melanoma/surgery , Pituitary Gland/surgery , Pituitary Neoplasms/surgeryABSTRACT
INTRODUCTION: Fibrous dysplasia is a non-neoplastic disorder of bone, related to abnormal proliferation of fibro-blasts. CASE REPORT: We report a 41-year-old female who presented with hyperprolactinaemia and an incidental clival lesion on MR scan. This was sub-totally resected via an endoscopic transsphenoidal approach and fibrous dysplasia was confirmed histologically. Her postoperative re-covery was un-eventful and at 8 months follow-up, she remains well, other than for the intermittent headaches and with no pituitary hormone deficiencies. CONCLUSION: The present case highlights the need to consider fibrous dysplasia in the differential diagnosis of isolated clival lesions.
Subject(s)
Cranial Fossa, Posterior/surgery , Craniotomy/methods , Endoscopy/methods , Fibrous Dysplasia of Bone/surgery , Sphenoid Bone/surgery , Adult , Cranial Fossa, Posterior/diagnostic imaging , Cranial Fossa, Posterior/pathology , Craniotomy/instrumentation , Female , Fibrous Dysplasia of Bone/diagnostic imaging , Fibrous Dysplasia of Bone/pathology , Humans , Hyperprolactinemia/etiology , Hyperprolactinemia/pathology , Hyperprolactinemia/physiopathology , Magnetic Resonance Imaging , Pituitary Gland/metabolism , Pituitary Gland/pathology , Pituitary Gland/physiopathology , Postoperative Complications/prevention & control , Radiography , Sphenoid Bone/diagnostic imaging , Sphenoid Bone/pathology , Treatment OutcomeABSTRACT
BACKGROUND: The POLG1 gene encodes the catalytic subunit of DNA polymerase gamma, essential for mitochondrial DNA replication and repair. Mutations in POLG1 have been linked to a spectrum of clinical phenotypes, and may account for up to 25% of all adult presentations of mitochondrial disease. METHODS AND RESULTS: We present 14 patients, with characteristic features of mitochondrial disease including progressive external ophthalmoplegia (PEO) and Alpers-Huttenlocher syndrome and laboratory findings indicative of mitochondrial dysfunction, including cytochrome c oxidase (COX) deficiency and multiple deletions or depletion of the mitochondrial DNA. Four novel POLG1 missense substitutions (p.R597W, p.L605R, p.G746S, p.A862T), are described, together with the first adult patient with a recently described polymerase domain mutation (p.R1047W). All novel changes were rare in a control population and affected highly conserved amino acids. CONCLUSION: The addition of these substitutions-including the first report of a dinucleotide mutation (c.1814_1815TT>GC)-to the growing list of defects further confirms the importance of POLG1 mutations as the underlying abnormality in a range of neurological presentations.
Subject(s)
DNA-Directed DNA Polymerase/genetics , Mitochondrial Diseases/genetics , Adolescent , Adult , Child , Cytochrome-c Oxidase Deficiency/genetics , Cytochrome-c Oxidase Deficiency/pathology , DNA Polymerase gamma , Diffuse Cerebral Sclerosis of Schilder/genetics , Diffuse Cerebral Sclerosis of Schilder/pathology , Female , Humans , Infant , Liver/ultrastructure , Male , Middle Aged , Mitochondrial Diseases/pathology , Muscle, Skeletal/ultrastructure , Mutation, Missense , Ophthalmoplegia, Chronic Progressive External/genetics , Ophthalmoplegia, Chronic Progressive External/pathology , Sequence AlignmentABSTRACT
The purpose of this study was to compare glucose metabolism, measured using 18F-fluorodeoxyglucose positron emission tomography ([18F]FDG-PET), with the expression of Glut-1 and -3 and hexokinase I (Hex I) and II in high-grade glioma. The retrospective study involved 27 patients with WHO classification grade III and IV glioma, with either newly diagnosed or recurrent tumours. Patients underwent dynamic and static [18F]FDG-PET to glucose metabolic rate (MRGlu) and standardised uptake value (SUV), respectively. Tumour biopsies were obtained and stained using immunohistochemistry for the expression of Glut-1, -3, Hex I and II. Relationships between variables were studied using Spearman's rank correlation test. Results showed that the expression of Glut-1, Glut-3, Hex I and Hex II varied between and within the tumour samples. The mean of MRGlu was 0.2 (range 0.09-0.25) micromol/min/ml and that of SUV was 4.2 (range 3.2-5.2). There were no significant relationships among the tumour expression of any of the proteins studied with either MRGlu or SUV (p>0.21 for all). In conclusion, the lack of relationship between the immunohistochemical expression of Glut-1, -3, Hex I or II and glucose metabolism measured using [18F]FDG-PET in patients with high-grade glioma may be due to the tissue heterogeneity and presence of necrosis in high-grade tumours.
Subject(s)
Astrocytoma/diagnostic imaging , Brain Neoplasms/diagnostic imaging , Fluorodeoxyglucose F18 , Glucose Transporter Type 1/metabolism , Glucose Transporter Type 3/metabolism , Hexokinase/metabolism , Positron-Emission Tomography/methods , Radiopharmaceuticals , Astrocytoma/metabolism , Astrocytoma/pathology , Biomarkers, Tumor/metabolism , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , Glucose/metabolism , Humans , Immunoenzyme Techniques , Prognosis , Retrospective StudiesABSTRACT
Spinal haemangiomas are benign vasoproliferative lesions that are typically intra-osseous and generally asymptomatic, although localized pain can be a symptom. Capillary and cavernous variants have been described. We describe a rare case of a dumbbell-shaped haemangioma of the thoracic spine with both an intraspinal-extradural and intrathoracic component.
Subject(s)
Hemangioma/diagnosis , Spinal Neoplasms/diagnosis , Thoracic Vertebrae , Diagnosis, Differential , Female , Hemangioma/surgery , Humans , Middle Aged , Spinal Neoplasms/surgery , Thoracic Vertebrae/surgery , Treatment OutcomeABSTRACT
Intracranial enterogenous cysts are an uncommon entity rarely found in the midline within the posterior cranial fossa. The occurrence of an enterogenous cyst in the cerebellopontine angle is exceptional. We present two new cases of cerebellopontine angle (CPA) enterogenous cysts and review the literature to clarify the diagnosis and the management of these lesions. Eighteen cases of CPA intradural enterogenous cysts have been reported to date, including the two cases presented in this article. All of them were symptomatic and underwent surgical treatment. After surgery, the symptomatic recurrence occurred in 31% of the patients, most of which had partial excision. Considering our patients and the published cases in the literature we suggest that the aim of surgery should be total removal of cyst and its content whenever possible. When partial resection of the cyst is performed, we recommend long-term clinical and neuroradiological follow-up.
Subject(s)
Cerebellar Diseases/diagnosis , Cerebellar Diseases/surgery , Cerebellopontine Angle , Cysts/diagnosis , Cysts/surgery , Adult , Cerebellar Diseases/complications , Cysts/complications , Female , Humans , Middle AgedABSTRACT
A patient fulfilling central, core and supportive clinical diagnostic criteria for dementia with Lewy bodies deteriorated rapidly in the absence of neuroleptic drug treatment, prompting suspicion of a diagnosis of sporadic Creutzfeldt-Jakob disease. At postmortem examination, the brain showed features typical of Creutzfeldt-Jakob disease of the MV1 subtype. We review the phenotypic overlap between dementia with Lewy bodies and Creutzfeldt-Jakob disease which may cause clinical misdiagnosis.
Subject(s)
Creutzfeldt-Jakob Syndrome/pathology , Diagnostic Errors , Lewy Body Disease/pathology , Aged , Cognition Disorders/etiology , Creutzfeldt-Jakob Syndrome/psychology , Humans , Lewy Body Disease/psychology , Male , PhenotypeABSTRACT
Gliomas are a heterogeneous group that account for approximately 86% of primary brain neoplasms, and include astrocytic and oligodendroglial tumours, as well as a variety of less common histopathological subtypes. Magnetic resonance imaging has become the accepted mode of imaging for the clinical management of these tumours. MRI features bear close resemblance to the histopathology grading and prognosis of these tumours. Currently, conventional MRI is used to aid diagnosis, plan neurosurgical approaches, and monitor response to therapy and disease progression. More recent developments in the field of MRI include MR spectroscopy, perfusion MRI, diffusion-weighted imaging, intraoperative MRI and functional MRI. These newer techniques have been adopted with varying success in the management of adult gliomas. This review focuses on the application of advanced MR imaging in the clinical management of adult gliomas.
Subject(s)
Brain Neoplasms , Glioma , Magnetic Resonance Imaging/methods , Magnetic Resonance Spectroscopy/methods , Brain Neoplasms/genetics , Brain Neoplasms/pathology , Brain Neoplasms/surgery , Glioma/genetics , Glioma/pathology , Glioma/surgery , Humans , Monitoring, Intraoperative/methods , Neurosurgical Procedures/methodsABSTRACT
The four GPI-anchored cell adhesion molecules that exemplify the IgLON family are most highly expressed in the nervous system and associate to form up to six different heterodimeric 'Diglons' that can modify cell adhesion and inhibit axon migration. Recently, two members, OPCML and LSAMP, were identified as putative tumour suppressor genes in ovarian and renal carcinomas respectively. In this study, we investigated OPCML expression in nonneoplastic brain tissue and 35 brain tumours (18 glioblastoma multiformes, five anaplastic gliomas, five meningiomas, six metastases and one medulloblastoma) and four glioma cell lines using quantitative reverse transcriptase polymerase chain reaction (RT-PCR). OPCML was highly expressed in cerebellum, less so in cerebral cortex, frontal lobe and meninges and was significantly reduced or absent in 83% of brain tumours and all cell lines compared with nonneoplastic whole brain. Two OPCML splice variants have been identified in humans, termed alpha1 and alpha2, but the latter has not been demonstrated in human neural tissues. Using PCR with specific primers, nonneoplastic brain and 3/6 of tested brain tumours expressed both splice variants, whereas the remaining brain tumours only expressed the alpha2 variant. Hypermethylation of the alpha1 OPCML promoter, associated with down-regulation of expression in ovarian tumours, did not correlate with expression levels in the subset of brain tumours tested, implying transcription of OPCML from an alternative promoter or a different mechanism of down-regulation. This study demonstrates that OPCML down-regulation occurs in the majority of brain tumours tested, warranting further investigation of OPCML and other IgLONs in the development and progression of brain tumours.
Subject(s)
Brain Neoplasms/genetics , Brain Neoplasms/metabolism , Cell Adhesion Molecules/genetics , Glioma/genetics , Glioma/metabolism , Alternative Splicing/genetics , Amino Acid Sequence , Cell Line, Tumor , DNA, Complementary/biosynthesis , DNA, Complementary/genetics , Down-Regulation , Exons/genetics , GPI-Linked Proteins , Gene Expression Regulation, Neoplastic , Humans , Methylation , Molecular Sequence Data , Promoter Regions, Genetic/genetics , RNA, Neoplasm/biosynthesis , RNA, Neoplasm/genetics , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
The -1p/-19q genotype predicts chemosensitivity in oligodendroglial neoplasms, but some with intact 1p/19q also respond and not all with 1p/19q loss derive durable benefit from chemotherapy. We have evaluated the predictive and prognostic significance of pretherapy (201)Tl and (18)F-FDG SPECT and genotype in 38 primary and 10 recurrent oligodendroglial neoplasms following PCV chemotherapy. 1p/19q loss was seen in 8/15 OII, 6/15 OAII, 7/7 OIII, 3/11 OAIII and was associated with response (Fisher-Exact: P=0.000) and prolonged progression-free (log-rank: P=0.002) and overall survival (OS) (log-rank: P=0.0048). Response was unrelated to metabolism, with tumours with high or low metabolism showing response. Increased (18)F-FDG or (201)Tl uptake predicted shorter progression-free survival (PFS) in the series (log-rank: (201)Tl P=0.0097, (18)F-FDG P=0.0170) and in cases with or without the -1p/-19q genotype. Elevated metabolism was associated with shorter OS in cases with intact 1p/19q (log-rank: (18)F-FDG P=0.0077; (201)Tl P=0.0004) and shorter PFS in responders (log-rank: (18)F-FDG P=0.005; (201)Tl P=0.0132). (201)Tl uptake and 1p/19q loss were independent predictors of survival in multivariate analysis. In this initial study, (201)Tl and (18)F-FDG uptake did not predict response to PCV, but may be associated with poor survival following therapy irrespective of genotype. This may be clinically useful warranting further study.
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Brain Neoplasms/genetics , Fluorodeoxyglucose F18/metabolism , Neoplasm Recurrence, Local/genetics , Oligodendroglioma/genetics , Adult , Aged , Alleles , Brain Neoplasms/drug therapy , Brain Neoplasms/pathology , Chromosomes, Human, Pair 1/genetics , Chromosomes, Human, Pair 19/genetics , Disease Progression , Female , Genetic Predisposition to Disease , Genotype , Humans , Lomustine/therapeutic use , Magnetic Resonance Imaging , Male , Middle Aged , Neoplasm Recurrence, Local/drug therapy , Neoplasm Recurrence, Local/pathology , Oligodendroglioma/drug therapy , Oligodendroglioma/pathology , Procarbazine/therapeutic use , Prospective Studies , Survival Rate , Tomography, Emission-Computed, Single-Photon , Tomography, X-Ray Computed , Treatment Outcome , Vincristine/therapeutic useABSTRACT
BACKGROUND: The -1p/-19q genotype has been associated with prolonged survival and chemosensitivity in oligodendroglial neoplasms, but the predictive and prognostic significance of genotype in the routine clinic is not established. METHODS: The authors investigated allelic imbalance in 1p36, 19q13, 17p13, 10p12-15, and 10q22-26 and p53 mutation in a cohort representative of clinical practice at their center (50 primary, 26 recurrent cases) given PCV chemotherapy between 2000 and 2003 and compared with response and outcome following PCV. RESULTS: 1p/19q loss was found in 12/19 OII, 10/23 OAII, 11/13 OIII, and 6/21 OAIII. Response, seen in 92% with 1p/19q loss, was associated with the -1p/-19q genotype (Fisher exact: p < 0.001) regardless of WHO grade or whether primary or recurrent. 1p/19q loss was an independent prognostic factor associated with longer progression-free (PFS) and overall survival (OS) (Cox regression: PFS and OS p < 0.001), with greater impact on PFS than OS in primary tumors, and OS at recurrence. 17p13 loss and p53 mutation were associated with poor prognosis in recurrent tumors and chromosome 10 loss was associated with short PFS and OS in primary tumors. Histologic subtype did not influence outcome in tumors of equivalent genotype. Genotype had greater association with response and outcome than conventional clinical factors. A total of 29% with intact 1p/19q and a variety of genetic or clinicopathologic characteristics responded in association with increased PFS and OS. CONCLUSIONS: The -1p/-19q genotype predicted response and favorable outcome following PCV chemotherapy corroborating genetic analysis to guide routine clinical management. However, some cases with intact 1p/19q also had clinical benefit.
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Brain Neoplasms/drug therapy , Brain Neoplasms/genetics , Oligodendroglioma/drug therapy , Oligodendroglioma/genetics , Risk Assessment/methods , Adult , Aged , Brain Neoplasms/mortality , Case-Control Studies , DNA Mutational Analysis , Female , Genetic Predisposition to Disease/genetics , Genotype , Humans , Lomustine/administration & dosage , Male , Middle Aged , Oligodendroglioma/mortality , Procarbazine/administration & dosage , Prognosis , Risk Factors , Survival Rate , Treatment Outcome , Vincristine/administration & dosageABSTRACT
Angiogenesis and extracellular matrix degradation are key events in tumour progression, and factors regulating stromal-epithelial interactions and matrix composition are potential targets for the development of novel anti-invasive/antiangiogenic therapies. Here, we examine the expression of ADAMTS-8, a secreted protease with antiangiogenic properties, in brain tissues. Using quantitative RT-polymerase chain reaction (PCR), high, equivalent expression of ADAMTS-8 was found in normal whole brain, cerebral cortex, frontal lobe, cerebellum and meninges. ADAMTS-8 expression in 34 brain tumours (including 22 high-grade gliomas) and four glioma cell lines indicated at least two-fold reduction in mRNA compared to normal whole brain in all neoplastic tissues, and no detectable expression in 14 out of 34 (41%) tumours or four out of four (100%) cell lines. In contrast, differential expression of TSP1 and VEGF was seen in nine out of 15 (60%) and seven out of 13 (54%) tumours, with no relationship in the expression of these genes. Immunohistochemistry and Western analysis indicated downregulation of ADAMTS-8 protein in >77% tumours. Methylation-specific PCR analysis of ADAMTS-8 indicated promoter hypermethylation in one out of 24 brain tumours (a metastasis) and three out of four glioma cell lines suggesting an alternative mechanism of downregulation. These data suggest a role for ADAMTS-8 in brain tumorigenesis, warranting further investigation into its role in regulation of tumour angiogenesis and local invasion.
Subject(s)
ADAM Proteins/metabolism , Angiogenesis Inhibitors/metabolism , Brain Neoplasms/metabolism , ADAM Proteins/genetics , ADAM Proteins/pharmacology , ADAMTS Proteins , Angiogenesis Inhibitors/genetics , Angiogenesis Inhibitors/pharmacology , Binding Sites , Blotting, Western , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Cell Line, Tumor , Down-Regulation , Gene Expression Profiling , Humans , Methylation , Promoter Regions, Genetic , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sensitivity and Specificity , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor A/metabolismABSTRACT
BACKGROUND: Meningeal melanocytoma was first described over 30 years ago as a benign tumour derived from melanocytes. Since then, data suggest that its mode of presentation is variable without a clear predilection for any particular site in the neuroaxis. Although classified as a benign tumour, this tumour shows a marked tendency towards reduced survival following subtotal resection and transformation over time in a limited number to malignant melanoma. Incomplete resection of these tumours without postoperative radiotherapy has only a 42% 5-year survival rate. Its classification as a benign tumour should be revised, given the published 5-year survival data. ILLUSTRATIVE CASE: We report a fatal case of meningeal melanocytoma in the cerebello-pontine angle in a 10-year-old child. This case exemplifies the vascular nature of these lesions even with minimal vascular blush on angiography. An updated literature search is presented, the results of which highlight the need for close follow-up and adjuvant treatment following subtotal resection.